Jacobson & Schmitt Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Hold
1,487
0.29% 46
2026
Q1
$1.37M Sell
1,487
-77
-5% -$78.1K 0.25% 42
2025
Q4
$1.68M Sell
1,564
-141
-8% -$135K 0.28% 41
2025
Q3
$1.3M Buy
1,705
+1
+0.1% +$744 0.22% 45
2025
Q2
$1.33M Buy
+1,704
New +$1.32M 0.24% 44
2025
Q1
Sell
-1,953
Closed -$1.51M 64
2024
Q4
$1.51M Sell
1,953
-84
-4% -$69.6K 0.29% 44
2024
Q3
$1.8M Sell
2,037
-3
-0.1% -$2.7K 0.37% 41
2024
Q2
$1.85M Buy
+2,040
New +$1.63M 0.42% 38
2024
Q1
Sell
-1,775
Closed -$1.03M 61
2023
Q4
$1.03M Sell
1,775
-29
-2% -$16.9K 0.26% 42
2023
Q3
$969K Buy
1,804
+29
+2% +$14.9K 0.28% 38
2023
Q2
$832K Hold
1,775
0.24% 40
2023
Q1
$610K Hold
1,775
0.18% 43
2022
Q4
$574K Hold
1,775
0.18% 39
2022
Q3
$574K Hold
1,775
0.18% 39
2022
Q2
$576K Hold
1,775
0.18% 38
2022
Q1
$508K Hold
1,775
0.13% 39
2021
Q4
$490K Buy
+1,775
New +$450K 0.12% 39

Other funds holding LLY

Jacobson & Schmitt Advisors's LLY Position: Q2 2026 in Review

Jacobson & Schmitt Advisors held its Eli Lilly (LLY) position steady in Q2 2026 at 1,487 shares worth $1.78M. The position accounts for 0.29% of the portfolio, ranked #46.

Jacobson & Schmitt Advisors first reported a position in LLY in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.85M in Q2 2024. 1,100 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Jacobson & Schmitt Advisors held 1,487 shares of Eli Lilly worth $1.78M as of Q2 2026.
  • Jacobson & Schmitt Advisors left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.29% of Jacobson & Schmitt Advisors's portfolio in Q2 2026, its #46 holding.
  • Jacobson & Schmitt Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 17 quarters since.
  • Jacobson & Schmitt Advisors's Eli Lilly position peaked at $1.85M in Q2 2024.
  • 1,100 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Jacobson & Schmitt Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.